Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Garden SpinCo was the temporary corporate vehicle created by 3M to hold its Food Safety business in connection with a Reverse Morris Trust transaction with Neogen. The business focused on commercial food safety testing and diagnostics products rather than therapeutics, including tools used for pathogen detection and broader food quality and safety workflows. On September 1, 2022, 3M completed the separation and Garden SpinCo merged with a subsidiary of Neogen, after which SpinCo became a wholly owned subsidiary of Neogen. As a result, Garden SpinCo did not continue as an independent operating biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Garden SpinCo.